Skip to main content

MoneyWorks4Me

Glenmark Pharmaceuticals informs about allotment of shares under ESOP

10 Aug 2026 Evaluate

Glenmark Pharmaceuticals has informed that the Company has allotted 23,863 Equity Shares of Re 1 each on August 10, 2026, to the grantee who had exercised the options under the Company's Employee Stock Option Plan 2016 (ESOP 2016). With this allotment, the paid-up capital of the Company has increased from Rs 28,22,00,809 divided into 28,22,00,809 number of equity shares of face value Re 1 each to Rs. 28,22,24,672 divided into 28,22,24,672 number of equity shares of face value Re 1 each. The details as required under the SEBI (Share Based Employee Benefits and Sweat equity) Regulations, 2021 are enclosed as Annexure - I.

The above information is a part of company’s filings submitted to BSE.  


Peers
Company Name CMP
Sun Pharma. Inds. 1870.05
Dr. Reddys Labs. 1387.00
Cipla 1383.00
Lupin 1953.90
Zydus Lifesciences 1202.70
View more..